Are the Pancreatic Serum Proteins Pancreatic Stone Protein (PSP) and Pancreatitis-Associated Protein (PAP) Predictive for the Development of Sepsis? Retrospective Study in Trauma Patients With Soft Tissue Defects.

Trauma Patients With Soft Tissue Defects Clinical Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00564109
• Other study ID #: StV 10-2003
• Status: Recruiting
• Phase: N/A
• First received: November 26, 2007
• Last updated: March 17, 2008
• Start date: August 2005
• Est. completion date: January 2008

Study information

• Verified date: November 2007
• Source: University of Zurich
• Contact: 01 Studienregister MasterAdmins
• Phone: +41 (0)44 255 11 11
• Is FDA regulated: No
• Health authority: Switzerland: Swissmedic
• Study type: Observational

Clinical Trial Summary

Retrospective analysis of PSP- and PAP-serum levels in trauma patients with soft tissue defects and possible correlation with the incidence and onset of infection and sepsis.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 15
• Est. completion date: January 2008
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 65 Years

Eligibility

Inclusion criteria:

• Trauma patients submitted to the university hospital Zurich, aged 18-65 with soft tissue defects

Exclusion criteria:

• Patients with known immunocompromising illnesses, drug abuse or infectious diseases.

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Trauma Patients With Soft Tissue Defects

Intervention

Procedure:
• retrospective Observation
retrospective Observation

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland,